Myelofibrosis:グローバル臨床試験レビューH2, 2013...市場調査レポートについてご紹介

【英文タイトル】Myelofibrosis Global Clinical Trials Review, H2, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Myelofibrosis 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Myelofibrosis 24
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in Myelofibrosis Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Incyte Corporation 33
Clinical Trial Overview of Incyte Corporation 33
Novartis AG 34
Clinical Trial Overview of Novartis AG 34
Sanofi 35
Clinical Trial Overview of Sanofi 35
S*BIO Pte Ltd 36
Clinical Trial Overview of S*BIO Pte Ltd 36
Novartis Pharmaceuticals Corporation 37
Clinical Trial Overview of Novartis Pharmaceuticals Corporation 37
Eli Lilly and Company 38
Clinical Trial Overview of Eli Lilly and Company 38
Celgene Corporation 39
Clinical Trial Overview of Celgene Corporation 39
Astex Therapeutics Limited 40
Clinical Trial Overview of Astex Therapeutics Limited 40
Cell Therapeutics, Inc. 41
Clinical Trial Overview of Cell Therapeutics, Inc. 41
Gemin X Pharmaceuticals 42
Clinical Trial Overview of Gemin X Pharmaceuticals 42
Luitpold Pharmaceuticals, Inc. 43
Clinical Trial Overview of Luitpold Pharmaceuticals, Inc. 43
Geron Corporation 44
Clinical Trial Overview of Geron Corporation 44
Promedior, Inc. 45
Clinical Trial Overview of Promedior, Inc. 45
Threshold Pharmaceuticals, Inc. 46
Clinical Trial Overview of Threshold Pharmaceuticals, Inc. 46
JW Pharmaceutical Corporation 47
Clinical Trial Overview of JW Pharmaceutical Corporation 47
Pfizer Inc. 48
Clinical Trial Overview of Pfizer Inc. 48
Millennium Pharmaceuticals, Inc. 49
Clinical Trial Overview of Millennium Pharmaceuticals, Inc. 49
YM BioSciences Inc. 50
Clinical Trial Overview of YM BioSciences Inc. 50
Infinity Pharmaceuticals, Inc. 51
Clinical Trial Overview of Infinity Pharmaceuticals, Inc. 51
Gilead Sciences, Inc. 52
Clinical Trial Overview of Gilead Sciences, Inc. 52
Clinical Trial Overview of Top Institutes / Government 53
The University of Texas M. D. Anderson Cancer Center 53
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 53
National Cancer Institute 54
Clinical Trial Overview of National Cancer Institute 54
Mount Sinai School of Medicine 55
Clinical Trial Overview of Mount Sinai School of Medicine 55
Fred Hutchinson Cancer Research Center 56
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 56
Mayo Clinic 57
Clinical Trial Overview of Mayo Clinic 57
Roswell Park Cancer Institute 58
Clinical Trial Overview of Roswell Park Cancer Institute 58
Memorial Sloan Kettering Cancer Center 59
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 59
The University of Utah 60
Clinical Trial Overview of The University of Utah 60
Massachusetts General Hospital 61
Clinical Trial Overview of Massachusetts General Hospital 61
Children’s Oncology Group 62
Clinical Trial Overview of Children’s Oncology Group 62
Thomas Jefferson University 63
Clinical Trial Overview of Thomas Jefferson University 63
Barbara Ann Karmanos Cancer Institute 64
Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute 64
Weill Cornell Medical College 65
Clinical Trial Overview of Weill Cornell Medical College 65
University of Ulm 66
Clinical Trial Overview of University of Ulm 66
Myeloproliferative Disorders-Research Consortium 67
Clinical Trial Overview of Myeloproliferative Disorders-Research Consortium 67
National Human Genome Research Institute 68
Clinical Trial Overview of National Human Genome Research Institute 68
City of Hope National Medical Center 69
Clinical Trial Overview of City of Hope National Medical Center 69
Gruppo Italiano Trapianto di Midollo Osseo 70
Clinical Trial Overview of Gruppo Italiano Trapianto di Midollo Osseo 70
Indiana University School of Medicine 71
Clinical Trial Overview of Indiana University School of Medicine 71
Odense University Hospital 72
Clinical Trial Overview of Odense University Hospital 72
Five Key Clinical Profiles 73
Appendix 154
Abbreviations 154
Definitions 154
Research Methodology 155
Secondary Research 155
About GlobalData 156
Contact Us 156
Disclaimer 156
Source 156


【レポート販売概要】

■ タイトル:Myelofibrosis:グローバル臨床試験レビューH2, 2013
■ 英文:Myelofibrosis Global Clinical Trials Review, H2, 2013
■ 発行日:2013年7月31日
■ 調査会社:GlobalData
■ 商品コード:GDATA403161499
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。